GenericsWeb Analyses Generic Opportunities for Merck’s Blockbuster Ezetimibe
GenericsWeb, the leader in established pharmaceutical patent analysis and searching, recently published an article based on its proprietary Pipeline Patent Intelligence that analyses opportunities in launching generic versions of Merck’s cholesterol lowering medicines Ezetrol®/Zetia® (Ezetimibe) and Inegy®/Vytorin® (Ezetimibe/Simvastatin) with reported global sales in 2010 of USD $2.3bn and $2.0bn respectively. (PRWEB) December 03, 2011 The article by GenericsWeb highlights the following observations in relation to generic Ezetimibe: Patent p
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Related Documents in PR Web
Categories
- Articles 309
- Bankruptcy 44
- Business 134
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4